Prescription RequiredLenvatinib 4 mg (Lenvenib) is a targeted anticancer medicine used to treat certain types of thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It belongs to the tyrosine kinase inhibitor (TKI) class of medicines and works by blocking proteins that promote tumour growth and the formation of new blood vessels. This helps slow the growth and spread of cancer cells and improves disease control.
| Generic name | Lenvatinib |
| Strength | 4 mg |
| Manufacturer | Sun Pharmaceutical |
| Package size | 7 Capsules |
| Used for | Thyroid, liver, kidney, and endometrial cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Lenvatinib is a tyrosine kinase inhibitor (TKI) that blocks multiple proteins, including VEGF and FGF receptors, which are involved in tumour growth and blood vessel formation. By blocking these signals, it helps reduce the tumour’s blood supply and slows the growth and spread of cancer cells.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
